Skip to content

The effectivity and feasibility of integrating nondispensing pharmacists into primary healthcare centres

Optimizing pharmacotherapy by redefining the role of the pharmacist: integration of the nondispensing pharmacist in the primary care team.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20964
Enrollment
8550
Registered
2014-01-07
Start date
2014-03-03
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Therapy Management - Farmacotherapie management Medication errors - Medicatiefouten Drug Utilization Review - Medicatiebeoordeling Polypharmacy - Polyfarmacie Aged - Ouderen Primary Health Care - Eerste lijns zorg Pharmacists - Apothekers Hospitalization - Hospitalisatie

Interventions

In a prospective, non-randomised controlled intervention with pre/post comparison (quasi experimental design) the outcomes of three implementation strategies with three models of pharmaceutical care p
B) In the community pharmacists with additional training arm, 10 pharmacists and their collaborating GP practices will be involved. The pharmacists will attend the ‘PIAF’ or the ‘Service ApotheekFarma

Sponsors

ZonMw Achmea
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Patients ≥ 60 years; - Polypharmacie (≥ 5 different chronic medications); - Use of cardiovasculair medication (ATC B/C); - Multi-morbidity (Frailty index ≥ 0.20)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
medication-related hospital admissions in elderly patients with multimorbidity, cardiovascular disease and polypharmacy.

Secondary

MeasureTime frame
cardiovascular events, quality indicators including blood pressure, laboratory markers and prescription indicators, the consumption of health care and related costs, prescription changes in elderly patients with multimorbidity, cardiovascular disease and polypharmacy.

Contacts

Public ContactA.J. Leendertse

Universitair Medisch Centrum Utrecht Julius Centrum voor Gezondheidswetenschappen en Eerstelijns Geneeskunde Heidelberglaan 100

a.j.leendertse-3@umcutrecht.nl0633825975

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)